$NBIO top asset is Pritumumab which targets brain, lung, breast, and pancreatic cancer.
https://biopharmajournal.com/2020/09/29/why-n...close-look $CODX $LAKE $AZN $COCP $AEMD $MRNA $CERS $CBLI $BRCX $APT $XAIR $NFH $VXRT $PURA $UOIP $KICK $SPRV $HUGE $RSHN $HHSE $NBDR $ACNNF $USMJ $PHGUF $WISH $ARGQ